A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells.

Like IL-12, IFN-gamma-inducing factor/IL-18 has been shown to stimulate T cells for IFN-gamma production and growth promotion. Considering the NK-stimulatory capacity of IL-12, we investigated the effect of IL-18 on NK lineage cells. A CD4- CD8- surface Ig- Ia- fraction of freshly prepared C57BL/6 spleen cells proliferated strikingly in response to combinations of IL-12 + IL-18 or IL-2 + IL-18, but not to the individual cytokines or IL-2 + IL-12. Cells proliferating in response to IL-2 + IL-18 were NK1.1+ CD3-, whereas IL-12 + IL-18-responsive cells were NK1.1- CD3-. Restimulation of the former cells with IL-12 + IL-18 or the latter cells with IL-2 + IL-18 resulted in the generation of NK1.1- CD3- or NK1.1+ CD3- cells, respectively. Moreover, a NK1.1+ CD3- CD4- CD8- surface Ig- Ia- population isolated from spleen cells was found to form NK1.1+ CD3- or NK1.1- CD3- blasts by stimulation with IL-2 + IL-18 or IL-12 + IL-18, respectively, and the NK1.1 positivity on these blasts was again reversed after restimulation with an alternative combined stimulus. Both types of blasts produced enormously large amounts of IFN-gamma in response to IL-12 + IL-18 and exhibited strikingly high levels of NK activity. These results indicate that IL-18 plays an obligatory role in inducing proliferation and activation of NK1.1+ CD3- CD4- CD8- cells and that the expression of the NK1.1 marker is reversible, depending on the cytokine used for stimulation in combination with IL-18.

[1]  H. Okamura,et al.  Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18. , 1998, Journal of immunology.

[2]  H. Okamura,et al.  A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. , 1997, Journal of immunology.

[3]  M Kurimoto,et al.  IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. , 1997, Journal of immunology.

[4]  T. Tanimoto,et al.  Interferon‐γ‐inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin‐12 for interferon‐γ production , 1996 .

[5]  T. Tanimoto,et al.  Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. , 1996, European journal of immunology.

[6]  C. Hunter,et al.  IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. , 1995, Journal of immunology.

[7]  G. Trinchieri,et al.  The role of natural killer cells in host-parasite interactions. , 1995, Current opinion in immunology.

[8]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-gamma production by T cells. , 1995, Nature.

[9]  G. Trinchieri.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[10]  J. Allison,et al.  CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. , 1994, Journal of immunology.

[11]  G. Trinchieri,et al.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.

[12]  G. Trinchieri,et al.  Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin‐12) on cell‐mediated cytotoxicity against tumor‐derived and virus‐infected cells , 1993, European journal of immunology.

[13]  P. Scott,et al.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice , 1993, The Journal of experimental medicine.

[14]  G. Bancroft.  The role of natural killer cells in innate resistance to infection. , 1993, Current opinion in immunology.

[15]  E. Unanue,et al.  Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Ritz,et al.  Costimulatory signals are required for optimal proliferation of human natural killer cells. , 1993, Journal of immunology.

[17]  G. Trinchieri,et al.  Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon 3,-Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Synthesis in Accessory Cells By Annalisa D'Andrea, Miguel Aste-Amezaga, , 1993 .

[18]  G. Trinchieri,et al.  Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. , 1992, Journal of immunology.

[19]  M. Gately,et al.  IL-12 receptor. II. Distribution and regulation of receptor expression. , 1992, Journal of immunology.

[20]  L. Lanier,et al.  Natural killer cells , 1992, Current Biology.

[21]  J. Ritz,et al.  Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells , 1992, European journal of immunology.

[22]  F. Podlaski,et al.  Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). , 1991, Journal of immunology.

[23]  R. Hewick,et al.  Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. , 1991, Journal of immunology.

[24]  G. Trinchieri,et al.  Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers , 1991, The Journal of experimental medicine.

[25]  B. Perussia,et al.  Lymphokine-activated killer cells, natural killer cells and cytokines. , 1991, Current opinion in immunology.

[26]  F. Podlaski,et al.  Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Horgan,et al.  Hyporesponsiveness of “naive” (CD45RA+) human T cells to multiple receptor‐mediated stimuli but augmentation of responses by co‐stimuli , 1990, European journal of immunology.

[28]  M. Caligiuri,et al.  Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors , 1990, The Journal of experimental medicine.

[29]  L. Lanier,et al.  Comparative studies of human FcRIII-positive and negative natural killer cells. , 1989, Journal of immunology.

[30]  G. Trinchieri,et al.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.

[31]  R. Coombs,et al.  Interleukin-2-induced production of interferon-gamma by resting human T cells and large granular lymphocytes: requirement for accessory cell factors, including interleukin-1. , 1988, Cellular immunology.

[32]  E. Unanue,et al.  A T cell-independent mechanism of macrophage activation by interferon-gamma. , 1987, Journal of immunology.

[33]  G. Trinchieri,et al.  Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. , 1986, Journal of immunology.

[34]  L. Lanier,et al.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis , 1986, The Journal of experimental medicine.

[35]  G. Trinchieri,et al.  Response of resting human peripheral blood natural killer cells to interleukin 2 , 1984, The Journal of experimental medicine.

[36]  E. Shevach,et al.  Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Ozato,et al.  MONOCLONAL ANTIBODIES TO MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS: IV. A SERIES OF HYBRIDOMA CLONES PRODUCING ANTI‐H-2d ANTIBODIES AND AN EXAMINATION OF EXPRESSION OF H‐2d ANTIGENS ON THE SURFACE OF THESE CELLS , 1982, Transplantation.

[38]  G. Shearer,et al.  The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes. , 1980, Journal of immunology.

[39]  J. Unkeless.  Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors , 1979, The Journal of experimental medicine.